Skip to main content
. 2020 Nov 11;32(6):496–507. doi: 10.5021/ad.2020.32.6.496

Fig. 1. Experimental protocol of this study. (A) Chemical structure of oxazolone. (B) Experimental protocol for the induction of AD-like skin and PM exposure. (C) Closed-system chamber attached to a nebulizer for PM exposure. AD: atopic dermatitis, PM: particulate matter, OXA: oxazolone.

Fig. 1